Translational Psychiatry, 2025 Optic disc morphometrics as a potential ocular biomarker for depression: evidence from two cross-sectional cohort studies
Zhang X., Wang S., Wang Y. et al.
Olink Explore 3072/384 Neurology Patient Stratification Plasma
Neurology Patient Stratification Plasma
Arthritis Research & Therapy, 2025 Inflammation-related proteomics of extracellular vesicles as novel biomarkers for systemic lupus erythematosus revealed by proximity extension assay
Zhan S., Wang Z., Xu Y. et al.
Olink Target 96 Immunological & Inflammatory Diseases Patient Stratification EV Lysate
Immunological & Inflammatory Diseases Patient Stratification EV Lysate
Journal of Assisted Reproduction and Genetics, 2025 Inflammatory proteomics of uterine fluid is potentially a non-invasive predictor for endometrial receptivity: a pilot study
Zeng H., Chang Y., Fu J. et al.
Olink Target 96 Obstetrics Patient Stratification Uterine Fluid
Obstetrics Patient Stratification Uterine Fluid
Respiratory Medicine, 2025 Plasma proteins associated with cardiovascular disease in relation to lung function in SCAPIS
Zaigham S., Liv P., Chorell E. et al.
Olink Target 96 CVD Respiratoy Diseases Pathophysiology Plasma
CVD Respiratoy Diseases Pathophysiology Plasma
Nature Communications, 2025 Proteome atlas for mechanistic discovery and risk prediction of diabetic retinopathy
Yang S., Xin Z., Xiong R. et al.
Olink Explore 3072/384 Metabolic Diseases Ophthalmology Patient Stratification Plasma
Metabolic Diseases Ophthalmology Patient Stratification Plasma
European Journal of Preventive Cardiology, 2025 Data-driven cluster analysis identifies distinct types of cardiovascular-kidney-metabolic syndrome
Yang M., Su C., Chang X. et al.
Olink Explore 3072/384 Metabolic Diseases Patient Stratification Plasma
Metabolic Diseases Patient Stratification Plasma
Cytokine, 2025 Serum protein profiles in lupus nephritis associated with initial-onset systemic lupus erythematosus: Characterization through PEA immunoassay and preliminary development of predictive model
Xiao D., Kong T., Wang T. et al.
Olink Target 96 Immunological & Inflammatory Diseases Patient Stratification Serum
Immunological & Inflammatory Diseases Patient Stratification Serum
Medicine, 2025 Identification of circulating inflammatory proteins as potential drug targets for sepsis through Mendelian randomization and colocalization analyses
Wan F., Shen J., Tang J.
Olink Explore 3072/384 Other Diseases & Syndromes Pathophysiology Plasma
Other Diseases & Syndromes Pathophysiology Plasma
Clinical Pharmacology & Therapeutics, 2025 Breaking Barriers: Characterization of the Intradermal Lipopolysaccharide Challenge as an
In Vivo
Model for Controlled Induction of Vascular Leakage in Healthy Volunteers
van Ruissen M., van Diemen M., Botros L. et al.
Olink Explore 3072/384 Technical Studies Pathophysiology Blister Fluid
Technical Studies Pathophysiology Blister Fluid
Transplantation, 2025 Early Postreperfusion Proteomics Reveal Divergent Inflammatory Responses in Kidney Transplantation with Implications on Outcomes
Strandberg G., Raihle C., Nilsson B. et al.
Olink Target 96 Immunological & Inflammatory Diseases Patient Stratification Plasma
Immunological & Inflammatory Diseases Patient Stratification Plasma
Frontiers in Medicine, 2025 Comprehensive proteome profiling of molecular endotypes in Japanese adults with moderate-to-severe atopic dermatitis
Serelli-Lee V., Ozeki A., Preuss C. et al.
Olink Explore 3072/384 Immunological & Inflammatory Diseases Dermatological Diseases Pathophysiology Patient Stratification Serum
Immunological & Inflammatory Diseases Dermatological Diseases Pathophysiology Patient Stratification Serum
European Journal of Pain, 2025 An Exploratory Study for Proteomic‐Based Markers of Joint Pain and Chronic Back Pain
Schillemans T., Rönnegård A., Assimes T. et al.
Olink Target 96 Neurology Patient Stratification Plasma
Neurology Patient Stratification Plasma
Biomedicine & Pharmacotherapy, 2025 Apremilast attenuates hepatic steatosis and metabolic dysfunction in a murine model of MASLD: Implications for patients with Psoriatic disease
Ruiz-Ponce M., Rodriguez-Cuenca S., Martin-Salazar J. et al.
Olink Target 96 Mouse Metabolic Diseases Hepatology Pathophysiology Mouse Tissue Lysate Mouse Serum
Metabolic Diseases Hepatology Pathophysiology Mouse Tissue Lysate Mouse Serum
Pediatric Research, 2025 Tracking the soluble biomarkers of MIS-C and their association with clinical parameters and severity
Pidkova T., Pino-Ramirez R., Urrea V. et al.
Olink Target 96 Immunological & Inflammatory Diseases Patient Stratification Serum
Immunological & Inflammatory Diseases Patient Stratification Serum
Cardiovascular Research, 2025 Single-cell to pre-clinical evaluation of
Trem2
,
Folr2
, and
Slc7a7
as macrophage-associated biomarkers for atherosclerosis
Örd T., Palani S., Giroud Gerbetant J. et al.
Olink Target 96 CVD Pathophysiology Plasma
CVD Pathophysiology Plasma
iScience, 2025 Targeted proteomics reveals immune protein patterns in serum from patients with calcific aortic stenosis
Mallia A., Binatti A., Sangiorgi D. et al.
Olink Target 96 CVD Pathophysiology Patient Stratification Serum
CVD Pathophysiology Patient Stratification Serum
Medicine, 2025 Exploring the causal relationship between gut microbiota, circulating metabolites, immune cells, and inflammation-related proteins and coronary artery calcification: A multi-omics Mendelian randomization study
Ma L., Xiao M., Cai S. et al.
Olink Target 96 CVD Pathophysiology Plasma
CVD Pathophysiology Plasma
Nutrition & Metabolism, 2025 Risk prediction of early-onset myocardial infarction using plasma proteomics, conventional risk factors, and polygenic risk score
Liu Z., Fang F., Qian Y. et al.
Olink Explore 3072/384 CVD Patient Stratification Plasma
CVD Patient Stratification Plasma
American Journal of Preventive Cardiology, 2025 Proteomic predictors of mortality among people with Coronary Artery Disease
Liu C., Hui Q., Quyyumi A. et al.
Olink Explore 3072/384 CVD Patient Stratification Plasma
CVD Patient Stratification Plasma
Hematology, 2025 Protein and gene levels of DNAJC21 and RNF5 as drug targets for immune thrombocytopenia: optimized post-GWAS insights
Li X., Li J., Lan Y. et al.
Olink Explore 3072/384 Immunological & Inflammatory Diseases Hematology Pathophysiology Plasma
Immunological & Inflammatory Diseases Hematology Pathophysiology Plasma